Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.

The Tencent-backed online cosmetic surgery marketplace has added an undisclosed nine-figure renminbi sum to the $60m it raised in January.

The Johns Hopkins spinout will funnel the cash into developing a class of glutamine antagonist that could help treat cancer.

The transdermal fluid removal spinout will aim for a close of at least $426,000 with another $99,400 from private investors.

Alexandria Venture Investments and 6 Dimensions Capital have participated in an oversubscribed second round for immunotherapy developer TCR2 Therapeutics.

Hospital and clinic operator Columbia Asia has secured $210m in a round that containted $140m from Mitsui, which had previously supplied $101m in 2016.

Illumina Ventures has led a series A1 round for Cernostics, a cancer diagnostics company that has now raised $13m from backers including UPMC Enterprises.

WuXi PharmaTech and Mayo Clinic-backed anti-ageing disease therapy developer Unity Biotechnology has secured series C funding to take its total equity financing to more than $200m.

Fidelity subsidiary Eight Roads Ventures has attracted $375m for a Europe and Israel-focused fund that will target enterprise, consumer, fintech and healthcare IT.